NO2490685T3 - - Google Patents
Info
- Publication number
- NO2490685T3 NO2490685T3 NO10778589A NO10778589A NO2490685T3 NO 2490685 T3 NO2490685 T3 NO 2490685T3 NO 10778589 A NO10778589 A NO 10778589A NO 10778589 A NO10778589 A NO 10778589A NO 2490685 T3 NO2490685 T3 NO 2490685T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25398509P | 2009-10-22 | 2009-10-22 | |
| PCT/EP2010/065961 WO2011048208A1 (en) | 2009-10-22 | 2010-10-22 | Causal therapy of diseases or conditions associated with cns or pns demyelination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2490685T3 true NO2490685T3 (no) | 2018-05-12 |
Family
ID=43332573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10778589A NO2490685T3 (no) | 2009-10-22 | 2010-10-22 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8962676B2 (no) |
| EP (1) | EP2490685B1 (no) |
| DK (1) | DK2490685T3 (no) |
| ES (1) | ES2664727T3 (no) |
| NO (1) | NO2490685T3 (no) |
| WO (1) | WO2011048208A1 (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2480214C1 (ru) * | 2011-09-22 | 2013-04-27 | Валентина Ивановна Ахапкина | Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов |
| CA3050086A1 (en) | 2017-03-26 | 2018-10-04 | Mapi Pharma Ltd. | Glatiramer depot systems for treating progressive forms of multiple sclerosis |
| WO2022164813A2 (en) * | 2021-01-26 | 2022-08-04 | The Regents Of The University Of California | Methods and compositions for targeting sv2 proteins for immune regulation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51149706A (en) | 1975-06-18 | 1976-12-22 | Nippon Telegr & Teleph Corp <Ntt> | Aural signal combining unit |
| CH657527A5 (de) * | 1980-02-13 | 1986-09-15 | Ciba Geigy Ag | Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist. |
| US6423739B1 (en) | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
| US6348489B1 (en) | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
| DE60138733D1 (de) * | 2000-12-28 | 2009-06-25 | Hamilton Pharmaceuticals Inc | Arzneimittel zur behandlung und vermeidung neurogener schmerzen |
| WO2003018005A1 (en) | 2001-08-22 | 2003-03-06 | Daiichi Pharmaceutical Co., Ltd. | use of nefiracetam for treating neurodegeneration |
| JP2005089299A (ja) | 2001-10-02 | 2005-04-07 | Dai Ichi Seiyaku Co Ltd | 注意欠陥多動性障害治療薬 |
| US20060241144A1 (en) | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
-
2010
- 2010-10-22 NO NO10778589A patent/NO2490685T3/no unknown
- 2010-10-22 ES ES10778589.1T patent/ES2664727T3/es active Active
- 2010-10-22 WO PCT/EP2010/065961 patent/WO2011048208A1/en active Application Filing
- 2010-10-22 EP EP10778589.1A patent/EP2490685B1/en active Active
- 2010-10-22 US US13/503,105 patent/US8962676B2/en active Active
- 2010-10-22 DK DK10778589.1T patent/DK2490685T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| US8962676B2 (en) | 2015-02-24 |
| EP2490685A1 (en) | 2012-08-29 |
| EP2490685B1 (en) | 2017-12-13 |
| DK2490685T3 (en) | 2018-03-26 |
| ES2664727T3 (es) | 2018-04-23 |
| US20120269762A1 (en) | 2012-10-25 |
| WO2011048208A1 (en) | 2011-04-28 |